Riskpilot← Back to searchSign inGet full accessConsilient Health AB
ABActiveOrg 5590868690StockholmActivities of agents involved in the wholesale of other particular products · NACE 4618Est. 20161 employees
Revenue 2025
SEK 4,8M
-19% vs 2024
EBITDA margin
4.7%
-20% vs 2024
Equity ratio
57.0%
Financial strength
Net profit 2025
SEK 181K
-19% vs 2024
| Revenue | SEK 4,8M | -19% |
| EBITDA | SEK 227K | -20% |
| Net profit | SEK 181K | -19% |
| Total assets | SEK 4,7M | +7% |
| Equity | SEK 2,7M | +7% |
| Employees | 1 | — |
Legal name
Consilient Health AB
Org number
5590868690
Legal form
Aktiebolag
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
24 november 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att distribuera och sälja läkemedel samt därmed förenlig verksamhet.
Address
Stockholm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 832 | 6 630 | 7 655 | 5 962 | 4 815 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 185 | 880 | 512 | 284 | 227 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 185 | 880 | 512 | 284 | 227 |
| Net financials | −5 | −12 | −3 | 1 | 3 |
| Profit before tax | 180 | 868 | 509 | 285 | 229 |
| Tax | −41 | −182 | −106 | −61 | −48 |
| Net profit | 139 | 686 | 403 | 224 | 181 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 214 | 3 453 | 4 288 | 4 335 | 4 656 |
| Equity | 1 161 | 1 848 | 2 251 | 2 475 | 2 656 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 052 | 1 605 | 2 038 | 1 860 | 2 000 |
| Total debt | 1 052 | 1 605 | 2 038 | 1 860 | 2 000 |
EBITDA margin
4.7%
This company
15.8%
Market median
-70% vs market
20212025
Equity ratio
57.0%
This company
38.2%
Market median
+49% vs market
20212025
Return on equity
6.8%
This company
18.4%
Market median
-63% vs market
20212025
Net profit margin
3.8%
This company
8.1%
Market median
-53% vs market
20212025
Asset turnover
1.03×
This company
1.12×
Market median
+8% vs market
20212025
Debt / equity
0.75×
This company
0.62×
Market median
+21% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BT Authorized Recipient of Service | Authorized Recipient of Service | 2020 |
SE Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CONSILIENT HEALTH LTD
Consilient Health AB (this company)Board members of Consilient Health AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Torsten Nilsson | Authorized Recipient of Service | 0 companies |
| Sara Elisabet Königslehner | Chief Auditor | 0 companies |
| John Culhane | Board of Directors | 0 companies |
| Luke Crosbie | Deputy Board Member | 0 companies |
| John Anthony Fagan | Board of Directors | 0 companies |